(Q57238650)

English

Direct-to-consumer pharmacogenomic testing

No description defined

In more languages

edit

Statements

0 references

0 references

Direct-to-consumer pharmacogenomic testing (English)

0 references

1 reference

Pascal Borry

2

0 references

Heidi Carmen Howard

series ordinal

1

object named as

Heidi Carmen Howard

0 references

publication date

October 2011

0 references

published in

Pharmacogenomics

0 references

volume

12

0 references

issue

10

0 references

page(s)

1367-1370

0 references

cites work

Predictive and diagnostic genetic testing in psychiatry

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Personal Genome Testing: Do You Know What You Are Buying?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Evaluation of risk prediction updates from commercial genome-wide scans

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Evaluating the utility of personal genomic information

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Ethical, Social and Legal Implications of Pharmacogenomics: A Critical Review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Social networkers' attitudes toward direct-to-consumer personal genome testing

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Pharmacogenetic testing: not as simple as it seems

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FPGS.11.100

retrieved

21 January 2018

Identifiers

DOI

10.2217/PGS.11.100

0 references

PubMed publication ID

22008043

0 references

(Q57238650)

Direct-to-consumer pharmacogenomic testing

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)